The Competition and Markets Authority (CMA) has raised (20 December) concerns about Synopsys’ proposed $35 billion acquisition of Ansys, citing potential risks to competition in the UK market for semiconductor chip design and light simulation software. However, the deal could still gain approval if the companies address the CMA’s issues.
Impact on Semiconductor and Light Simulation Software Markets
The merger unites two major players in industries critical to everyday technologies like smartphones, laptops, and AI systems, as well as sectors such as cloud computing, automotive, and aerospace. Semiconductor chip design software is integral to creating the chips powering these devices, while light simulation software supports innovations in products such as camera lenses, TV displays, and lasers.
The CMA’s Phase 1 investigation revealed that while Synopsys and Ansys largely offer complementary products, they compete closely in three key areas:
- Global Register Transfer Level Power Consumption Analysis: Software used to evaluate the power needs of semiconductor chips.
- Global Optics Software: Tools for designing and modeling light-related products.
- Global Photonics Software: Technology critical to light-based product development.
The CMA fears the merger could stifle innovation, reduce customer choice, and lead to higher prices for businesses and consumers in the UK.
Companies’ Opportunity to Address Concerns
Synopsys and Ansys now have the chance to propose solutions to mitigate these concerns. Without adequate remedies, the CMA could escalate the investigation to Phase 2 review.
“Synopsys and Ansys are important suppliers of semiconductor chip design and light simulation software, and we’re concerned that this deal could reduce innovation and lead to higher prices for these products in the UK,” said Naomi Burgoyne, Senior Director of Mergers at the CMA.
Global Implications
The merger is also under scrutiny in other jurisdictions, including the EU, US, China, Japan, and South Korea. The CMA has collaborated with international regulators during its assessment.
The CMA’s investigation ultimately found no significant risk of Synopsys or Ansys limiting competitors’ access to critical software products or degrading interoperability with rival systems.
Next Steps
If the companies fail to address the CMA’s concerns, the deal will be subject to an in-depth Phase 2 investigation.
